| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |